Stressing that support is paramount to coping with diabetes management, the Maryland-based National Institutes of Health recently urged individuals dealing with the diagnosis to seek out resources and encouragement during November — National Diabetes Month.
Leaders with the Fibrous Dysplasia Foundation and the National Organization for Rare Disorders recently launched a new study with the goal of researching fibrous dysplasia/McCune-Albright syndrome (FD/MAS).
Evanston, Illinois-based Aptinyx Inc., a biopharmaceutical company advancing therapies for neurological disorders, recently obtained $2.85 million in NIH grants to spearhead research on neuropathic pain and age-related cognitive decline.
New data from an American Heart Association report indicate that a cancer survivor’s age at diagnosis may directly relate to their chances of succumbing to heart disease, with a younger onset age suggesting increased risk.
The American Heart Association (AHA) recently developed a new assessment tool called the Million Hearts Model Longitudinal ASCVD Risk Assessment tool, which may improve accuracy for determining heart disease risks.
Sharon Byers, who has served the American Cancer Society in a fundraising leadership role over the past year, will now take the helm as the group’s chief development and marketing officer, a newly expanded position.
Leaders with the National Patient Safety Foundation (NPSF) and the Centers for Disease Control and Prevention (CDC) recently partnered for the ninth annual Get Smart About Antibiotics Week to fight against antibiotic resistance.
Leaders and officials with Takeda Pharmaceutical Company Limited recently highlighted their sustained commitment to fighting Hodgkin lymphoma at the 10th International Symposium on Hodgkin Lymphoma (ISHL) in Germany.
The University of California at Los Angeles’ (UCLA) Center for Duchenne Muscular Dystrophy (CDMD) was recently selected as the 12th clinic to become a Certified Duchenne Care Center by Parent Project Muscular Dystrophy (PPMD).
In the 'Journal of Autism and Developmental Disorders,' a team of researchers recently wrote that some doctors may be unknowingly over-diagnosing children with autism as having attention deficit hyperactivity disorder (ADHD).
The Bristol-Myers Squibb Foundation has decided to join the Obama administration’s Cancer Moonshot initiative by committing $25 million to community-based cancer treatment, care and support for underserved patients.
Researchers unveiled new information this week in the American Heart Association’s journal 'Circulation,' showing that people with pacemakers or defibrillators who experience short episodes of atrial fibrillation have a very low risk of stroke.
The Leukemia and Lymphoma Society (LLS) recently launched a collaborative clinical trial for acute myeloid leukemia (AML), a deadly disease for which treatments have not improved much in the last four decades.
Boehringer Ingelheim announced this week its intent to join The Leukemia and Lymphoma Society's (LLS) Beat AML initiative, which aims to advance treatments for patients with acute myeloid leukemia (AML).
The National Institutes of Health (NIH) National Eye Institute (NEI) recently funded a study that evaluated the role of the visual cortex, the sensory information processing region of the brain, in plasticity of reflexive eye movements.
Leaders with the National Multiple Sclerosis (MS) Society recently invested over $10.5 million in funding for 42 new MS research projects that are designed to stop MS, bring back lost functions and ultimately eradicate the disease.